首页 › 乳腺癌 › 得克萨斯州 › League City
League City TX 乳腺癌临床试验
12项针对 乳腺癌的研究正在 League City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
招募中观察性研究
- MD Anderson League City, Nassau Bay · 距离 3 英里
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
招募中1 期
- NEXT Houston, Galveston · 距离 23 英里
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Tranquility Research, Webster · 距离 3 英里
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 距离 3 英里
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Tranquil Clinical Research, Webster · 距离 3 英里
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
招募中2 期
- Tranquil Clinical Research, Webster · 距离 3 英里
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
招募中1 期
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 距离 3 英里
- University of Texas Medical Branch, Galveston · 距离 23 英里
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
招募中
- University of Texas Medical Branch at Galveston, TX, Galveston · 距离 23 英里
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
招募中欢迎健康志愿者
- The University of Texas Medical Branch, Galveston, Galveston · 距离 23 英里
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
招募中观察性研究
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 距离 3 英里
其他城市的 乳腺癌试验
- New York City, NY137 项研究
- Houston, TX127 项研究
- Boston, MA113 项研究
- Nashville, TN80 项研究
- Los Angeles, CA72 项研究
- Edison, NJ67 项研究
- St. Louis, MO65 项研究
- Durham, NC64 项研究
- Queens, NY63 项研究
- Chicago, IL59 项研究
- Philadelphia, PA57 项研究
- Dallas, TX56 项研究
League City的其他研究
- 非小细胞肺癌15 项研究
- 转移性癌症7 项研究
- 结直肠癌6 项研究
- 溃疡性结肠炎6 项研究
- 肺癌6 项研究
- 癌症（所有类型）5 项研究
- 卵巢癌5 项研究
- 卒中5 项研究
- 前列腺癌4 项研究
- 膀胱癌4 项研究
- 头颈鳞状细胞癌4 项研究
- 新冠后遗症（长新冠）3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。